Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

$10M NIH grant to reduce cardiovascular disease risk among Latinos in East Los Angeles

The UCLA School of Public Health today announced a $10 million grant from the National Institutes of Health to fund a Center for Population Health and Health Disparities in partnership with the University of Southern California, the Los Angeles County Department of Public Health and several community collaborators.

4 May 2010

tPA drug effective in treating stroke symptoms

When Ruth Mitchell arrived at Loyola University Hospital's emergency room, her face was drooping, her left arm was weak, she couldn't walk and she was slurring her words.

4 May 2010

Natural plant extract could help treat COPD and inflammatory disorders

A widely and safely used plant extract acts as a novel anti-inflammatory agent that may one day be used for the treatment of chronic obstructive pulmonary disease, or COPD, as well as other inflammatory conditions.

4 May 2010

Hormone-like inner ear signaling system protects against noise-induced hearing loss

An in vivo study shows for the first time that there is a stress-response system within the cochlea that mirrors the signaling pathways of the body's fight or flight response. Researchers have identified a hormone-like signaling system of the inner ear that sets baseline hearing sensitivity and helps protect against noise-induced hearing loss.

4 May 2010

Trajectory Health, HeartMath partner to deliver clinical stress management solutions to corporates

Dallas-based Trajectory Health, LLC has announced a partnership with HeartMath® to deliver clinical stress management solutions to the corporate marketplace.

4 May 2010

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Forest Laboratories, Inc. today presented data from a Phase IV study evaluating the effects of Bystolic (nebivolol) tablets in Hispanic patients with hypertension at the 2010 annual scientific meeting of the American Society of Hypertension.

4 May 2010

Medtronic completes enrollment in first of two CURE-AF clinical trials

Medtronic, Inc., today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant Utilization of Radiofrequency Energy for Atrial Fibrillation) clinical trial.

4 May 2010

FDA issues advisory on prostate cancer drugs

Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.

3 May 2010

Intouch Health completes $10M private placement through Beringea-led financing round

InTouch Technologies®, Inc. (d.b.a. InTouch Health®), the world leader in Remote Presence Total Telemedicine solutions, announced today the completion of a private placement of $10 million. The financing round was led by Michigan-based Beringea through its InvestMichigan! Growth Capital Fund, which provides venture and expansion-stage capital to businesses with operations in Michigan.

3 May 2010

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

In the current issue of Psychotherapy and Psychosomatics a group of German investigators examines the literature concerned with the effects of interventions involving the family in the treatment of patients with chronic disease.

3 May 2010

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition demonstrate a link between short cycles of sleep, stroke and silent cerebral infarct, or "silent strokes," in elderly hypertensive patients.

3 May 2010

Leptin hormone controls immune’s response to sepsis: Study

The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.

3 May 2010

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.

3 May 2010

New 3-D mapping and labeling system reduces scan time and improves work flow

Researchers have developed an automated 3-D mapping and labeling system that reduces scan time and improves the work flow, efficiency, and accuracy of routine freehand ultrasound exams, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

3 May 2010

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) indicate that in men with high cardiovascular risk, left ventricular mass may help better predict future cardiovascular and renal outcomes, including hemodialysis.

3 May 2010

Majority of patients who appear healthy may be at risk for cardiovascular disease

Three separate studies announced today at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) examined the cardiovascular consequences of relatively healthy patients - those who were asymptomatic and not classified as hypertensive or diabetic - and found that many patients who appear healthy may still be at risk for cardiovascular disease.

3 May 2010

VIMOVO delayed-release tablets receive FDA approval

AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

3 May 2010

New tool may help neurologists predict candidates for organ donation

A new tool may help neurologists predict which coma patients may be candidates for organ donation, according to a study published in the April 27, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

3 May 2010

Study finds multiple brain regions used to decipher sentences

A new study from the University of Rochester finds that there is no single advanced area of the human brain that gives it language capabilities above and beyond those of any other animal species.

30 Apr 2010

Excess urinary protein excretion increases risk of kidney, heart complications in people with hypertension

Healthy people with high blood pressure who excrete a slight excess of protein in the urine raise their risk of developing kidney and heart complications. According to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN), more attention should focus on the potential health effects of urinary protein excretion in individuals with high blood pressure (hypertension).

30 Apr 2010

Stroke News and Research

Further Reading

$10M NIH grant to reduce cardiovascular disease risk among Latinos in East Los Angeles

tPA drug effective in treating stroke symptoms

Natural plant extract could help treat COPD and inflammatory disorders

Hormone-like inner ear signaling system protects against noise-induced hearing loss

Trajectory Health, HeartMath partner to deliver clinical stress management solutions to corporates

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Medtronic completes enrollment in first of two CURE-AF clinical trials

FDA issues advisory on prostate cancer drugs

Intouch Health completes $10M private placement through Beringea-led financing round

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

Leptin hormone controls immune’s response to sepsis: Study

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

New 3-D mapping and labeling system reduces scan time and improves work flow

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Majority of patients who appear healthy may be at risk for cardiovascular disease

VIMOVO delayed-release tablets receive FDA approval

New tool may help neurologists predict candidates for organ donation

Study finds multiple brain regions used to decipher sentences

Excess urinary protein excretion increases risk of kidney, heart complications in people with hypertension

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News